Looking for an industrial verification environment for your innovative bioprocess technology?
Welcome to Testa Challenge!
Having access to a relevant verification environment in bio production is a limiting factor for many technological / digital innovations (Are you new to bioproduction? Find out why this fast-growing market is interesting for you here). Raising enough capital to perform a live test in an industrial process can be a challenge for start-ups and researchers, which puts pressure to reach set milestones.
Therefore, at Testa Center, we open our laboratories this fall for a week, both for academic and commercial innovators in the technical or digital field who would have the potential to increase the efficiency or quality of a bioprocess workflow. This unique challenge allows participants to integrate and verify their innovation in an authentic and validated bioprocess run.
Biological drugs and products are transforming medicine and promise future targeted treatments for a range of conditions. However, in order for these powerful products to benefit all people in the world, a large number of new technologies and tools that can drastically improve productivity of biological production are needed. New methods, processes and approaches are required to accelerate innovation in this area. We have identified three main challenges within the field of bio-processing;
We know that there are countless promising technologies out there. We also know that, as a young technology developing company, it can be a significant threshold to get access to a relevant industrial verification environment. In order to address this gap, Testa Center now invite you to apply to Testa Challenge.
Projects and companies from the Technology/ Digital/ Data segment are invited to integrate, test and verify their innovation within a sponsored and provided bioproduction workflow at the Testa Centre. Alongside the production process, participants will be supported by experts. The provided facilities, expertise and fast-tracked application will allow an early evaluation whether the innovation is applicable and successful for the bioprocessing industry. The production process will be designed to include ~5 selected technologies and run in Testa Center during October 2020*.
*Pending Corona-pandemic restrictions